{"address1": "825 Industrial Road", "address2": "Suite 300", "city": "San Carlos", "state": "CA", "zip": "94070", "country": "United States", "phone": "650 837 0111", "website": "https://vaxcyte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD). The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV being developed for the prevention of IPD in adults and children. VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI to prevent dysentery and shigellosis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.", "fullTimeEmployees": 414, "companyOfficers": [{"maxAge": 1, "name": "Mr. Grant E. Pickering M.B.A.", "age": 56, "title": "Co-Founder, CEO & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 1134484, "exercisedValue": 1200920, "unexercisedValue": 56101660}, {"maxAge": 1, "name": "Mr. Andrew L. Guggenhime M.B.A.", "age": 56, "title": "President & CFO", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 820809, "exercisedValue": 1897544, "unexercisedValue": 31047676}, {"maxAge": 1, "name": "Mr. James  Wassil M.B.A., M.S.", "age": 54, "title": "Executive VP & COO", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 521046, "exercisedValue": 943616, "unexercisedValue": 17866998}, {"maxAge": 1, "name": "Mr. Mikhail  Eydelman J.D.", "age": 42, "title": "Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 684617, "exercisedValue": 930636, "unexercisedValue": 3067545}, {"maxAge": 1, "name": "Dr. Jeff  Fairman Ph.D.", "age": 59, "title": "Co-Founder & VP of Research", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Graesser", "title": "Senior Vice President of Corporate Communications & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Whitney  Jones", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul W. Sauer M.B.A.", "age": 62, "title": "Senior Vice President of Process Development & Manufacturing", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 608956, "exercisedValue": 0, "unexercisedValue": 6361555}, {"maxAge": 1, "name": "Mr. Harp  Dhaliwal M.B.A.", "age": 50, "title": "Chief Technical Operations Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 146484, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Sam  Iki", "title": "Senior Vice President of Project Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 37.76, "open": 37.12, "dayLow": 31.79, "dayHigh": 37.92, "regularMarketPreviousClose": 37.76, "regularMarketOpen": 37.12, "regularMarketDayLow": 31.79, "regularMarketDayHigh": 37.92, "payoutRatio": 0.0, "beta": 1.023, "forwardPE": -6.8428874, "volume": 8883818, "regularMarketVolume": 8883818, "averageVolume": 1489940, "averageVolume10days": 3069240, "averageDailyVolume10Day": 3069240, "bid": 27.22, "ask": 41.12, "bidSize": 1, "askSize": 2, "marketCap": 4149999104, "fiftyTwoWeekLow": 30.12, "fiftyTwoWeekHigh": 121.055, "fiftyDayAverage": 78.0819, "twoHundredDayAverage": 88.85358, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2473889024, "profitMargins": 0.0, "floatShares": 119166306, "sharesOutstanding": 128762000, "sharesShort": 12609286, "sharesShortPriorMonth": 13334612, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0979, "heldPercentInsiders": 0.00501, "heldPercentInstitutions": 1.11758, "shortRatio": 9.92, "shortPercentOfFloat": 0.1107, "impliedSharesOutstanding": 128762000, "bookValue": 26.469, "priceToBook": 1.2176508, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -463927008, "trailingEps": -3.8, "forwardEps": -4.71, "enterpriseToEbitda": -4.398, "52WeekChange": -0.5049155, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 32.23, "targetHighPrice": 163.0, "targetLowPrice": 65.0, "targetMeanPrice": 128.44444, "targetMedianPrice": 137.0, "recommendationMean": 1.2, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 1747207936, "totalCashPerShare": 13.569, "ebitda": -562542976, "totalDebt": 71110000, "quickRatio": 12.611, "currentRatio": 12.755, "debtToEquity": 2.151, "returnOnAssets": -0.14472, "returnOnEquity": -0.20409, "freeCashflow": -403444256, "operatingCashflow": -452627008, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PCVX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Vaxcyte, Inc.", "longName": "Vaxcyte, Inc.", "preMarketChange": 0.010002136, "preMarketChangePercent": 0.031033622, "preMarketPrice": 32.24, "regularMarketChange": -5.529999, "regularMarketDayRange": "31.79 - 37.92", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1489940, "fiftyTwoWeekLowChange": 2.1099987, "fiftyTwoWeekLowChangePercent": 0.07005308, "fiftyTwoWeekRange": "30.12 - 121.055", "fiftyTwoWeekHighChange": -88.825, "fiftyTwoWeekHighChangePercent": -0.7337574, "fiftyTwoWeekChangePercent": -50.491547, "earningsTimestamp": 1740517260, "earningsTimestampStart": 1746561600, "earningsTimestampEnd": 1747080000, "earningsCallTimestampStart": 1740519000, "earningsCallTimestampEnd": 1740519000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.8, "epsForward": -4.71, "epsCurrentYear": -4.278, "priceEpsCurrentYear": -7.5338945, "fiftyDayAverageChange": -45.851902, "fiftyDayAverageChangePercent": -0.5872283, "twoHundredDayAverageChange": -56.623577, "twoHundredDayAverageChangePercent": -0.6372684, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591968600000, "regularMarketChangePercent": -14.645125, "regularMarketPrice": 32.23, "corporateActions": [], "preMarketTime": 1743596842, "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_307500026", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "displayName": "Vaxcyte", "trailingPegRatio": null}